Tuesday, September 11, 2012
Abbott continues to expand contract manufacturing capabilities of its multi-product potent facility through the recent installment of a new roller compactor. This new granulation equipment addresses the growing needs ofsolid dose potent formulations. This new capability will provide customers with the proper flexibility and efficiency needed to advance their drug product needs.
Abbott's potent API and drug product contract manufacturing facility is located in Sligo, Ireland. The facility also offers wet granulation, compression, coating and tableting processes for potent compounds, in addition to the new granulation capabilities.